All Hypersensitivity, Immediate Articles
- Review of animal models for allergic fungal airway disease and asthma
- Meta-analysis identifies key risk factors for food allergy in young children
- Probiotic co-administration with berotralstat improves GI tolerability in HAE patients
- Lanadelumab reduced attacks in Chinese adults with hereditary angioedema over six months
- Narrative review identifies emerging associations between gut microbiota and pediatric eye conditions
- Protocol for HRF-HMO vs eHF-HMO in infants with suspected cow's milk allergy
- In a single-center retrospective cohort of 107 pediatric patients, food was the most common anaphylaxis trigger at 62.61%
- Study Protocol Evaluating Hydrolyzed Rice Protein Formula Safety in Infants With Cow's Milk Allergy
- FDA Approves Dupixent (dupilumab) for Allergic Fungal Rhinosinusitis in Patients with History of Sino-Nasal Surgery
- Gut microbial IgA coating levels in infancy differ between urban and agrarian cohorts, linked to allergic outcomes
- AQST-109 sublingual film shows faster time-to-peak concentration than epinephrine autoinjectors in healthy adults
- A single case report confirms rare IgE-mediated cocoa allergy causing anaphylaxis in a child
- Peri- and postmenopausal hormonal changes may exacerbate asthma, rhinitis, cough, allergies, hypersensitivity, anaphylaxis, and angioedema
- Systematic review finds moderate to substantial concordance among fungal sIgE detection kits for asthma
- Early proactive TCS for infant AD linked to lower food allergy rates at age 3
- U.S. deaths from hornet, wasp, and bee stins tracked from 2011 to 2021
- Oral deucrictibant reduced hereditary angioedema attack rates versus placebo in a phase 2 trial
- Oral deucrictibant reduces hereditary angioedema attack severity in phase 2 crossover trial
- Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% between 2007 and 2018
- Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% over 11 years
- Anaphylaxis cases reported after first dose of Pfizer-BioNTech COVID-19 vaccine in US surveillance
- Surveillance reports anaphylaxis cases after first Moderna COVID-19 vaccine doses in US
- Neuroimmune mechanisms may sustain urticaria pruritus and contribute to treatment resistance